Emergent BioSolutions | EBS - Ebitda

Prezzo Delle Azioni
9.50
Cambio Giornaliero
0.37 4.05%
Mensile
12.43%
Annuale
68.14%
Q2 Previsione
8.94




Ebitda Cambiamento Data
Acadia Pharmaceuticals USD 20.31M 15.44M 2025-12
Akebia Therapeutics USD 14.03M 17.19M 2025-03
ALKERMES USD 80.26M 20.05M 2026-03
Alnylam Pharmaceuticals USD 145.22M 236.56M 2025-12
Amarin USD 12.54M 28.57M 2025-06
ANI Pharmaceuticals USD 65.36M 5.76M 2025-12
BioMarin Pharmaceutical USD 146.05M 170.22M 2026-03
Coherus Biosciences USD -43.33M 4.7M 2025-09
Exelixis USD 242.86M 6.08M 2025-12
Glaxosmithkline GBP 4.75B 1.52B 2025-09
Heron Therapeutics USD -3.88M 5.63M 2024-09
Ionis Pharmaceuticals USD -200.02M 42.89M 2025-12
Ironwood Pharmaceuticals USD 81.81M 31.71M 2025-09
Lexicon Pharmaceuticals USD -12.04M 15.95M 2025-09
Lonza CHF 1.01B 54M 2025-12
Merck USD 6.3B 2.09B 2025-12
Moderna USD -790M 582M 2025-12
Myriad Genetics USD 14.3M 4M 2025-12
Nektar Therapeutics USD -31.81M 70K 2023-09
Neurocrine Biosciences USD 218.4M 28.3M 2025-12
Pacira USD 40.24M 1.53M 2026-03
Pfizer USD 5.99B 5.23B 2026-03
PTC Therapeutics USD -70.99M 91.62M 2025-12
Sanofi EUR 3.31B 3.65B 2026-03
Sarepta Therapeutics USD -252.2M 84.16M 2025-12
United Therapeutics USD 379.5M 83.4M 2025-12
Vanda Pharmaceuticals USD -8.31M 2.37M 2024-12
Xoma USD 2.52M 7.98M 2024-06